Leading the market with GMP-certified manufacturing and rigorous quality control.
In the modern pharmaceutical landscape, the role of a Generic Drugs Manufacturer has transitioned from mere duplication to sophisticated bio-equivalent engineering. Today, the global generic market is valued at over USD 400 billion, driven by the escalating demand for affordable healthcare and the "patent cliff" where many blockbuster drugs are losing exclusivity.
As a leading factory in China, we recognize that the industry is no longer just about cost-cutting; it is about Supply Chain Resilience and Manufacturing Excellence. Global healthcare systems—from the United States to Southeast Asia—are increasingly relying on high-quality generics to manage chronic diseases, veterinary health, and acute infections.
Our facility in Hangzhou leverages advanced chemical synthesis and AI-driven process optimization to ensure that every batch of Active Pharmaceutical Ingredients (APIs) meets international pharmacopoeia standards (USP, BP, EP).
Navigating the future of pharmaceutical sourcing with data-driven insights.
The "Smart Factory" concept is revolutionizing how we manufacture pharmaceutical intermediates. By integrating AI monitoring systems, we can predict chemical reaction outcomes with 99% accuracy, reducing waste and ensuring the highest purity levels for products like Metronidazole and Ceftiofur Sodium.
The industry is shifting toward "Complex Generics"—drugs that are harder to formulate, such as sterile injectables and sustained-release tablets. Our R&D team in Hangzhou is at the forefront of this shift, focusing on high-barrier products that require specialized manufacturing environments and complex regulatory filing processes.
Global enterprises are moving away from single-source procurement to "China + 1" strategies. They require partners who not only offer competitive pricing but also provide comprehensive Regulatory Support and Custom Manufacturing (CDMO) services. This is where Hangzhou Jeci Biochem excels, bridging the gap between raw chemical production and market-ready pharmaceutical applications.
In regions with thriving agricultural sectors, such as Southeast Asia and Latin America, the demand for high-quality generic veterinary drugs is paramount. Our generic formulations are designed to provide the same therapeutic efficacy as original brands but at a fraction of the cost, ensuring animal welfare is accessible to all farmers and pet owners.
Whether it is treating parasitic infections in livestock or managing cardiac health in companion animals, our products are formulated for specific regional environmental challenges.
Your Strategic Partner in Chemical & Pharmaceutical Excellence.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Our generic drugs and intermediates are widely utilized across various industrial sectors:
Utilizing automation and precision engineering for high-capacity drug manufacturing.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
China remains the world's powerhouse for API production. Our advantage lies in the integration of a Complete Supply Chain—from raw petrochemicals to refined active substances. This allows us to offer pricing that is significantly more competitive than European or American counterparts without compromising on the Quality Assurance required by global regulators.
By partnering with Hangzhou Jeci Biochem, you gain access to a network of R&D institutes and a manufacturing floor that can scale from pilot batches to metric tons in weeks, not months.
As the industry evolves, "Green Chemistry" has become a non-negotiable standard. We are investing in solvent recovery systems and catalytic processes that minimize environmental impact. A responsible Generic Drugs Manufacturer must balance the urgent need for affordable medicine with the global commitment to carbon neutrality.
Furthermore, the Bio-pharmaceutical revolution is introducing biosimilars into the generic drug conversation. These are biological products that are highly similar to already approved reference products. Hangzhou Jeci Biochem is actively exploring the synthesis of complex peptides and protein-based intermediates to stay ahead of this high-tech curve.
In the procurement cycle, reliability is the ultimate currency. Global enterprises seek manufacturers who can provide:
Consistent quality across our entire range of synthetic and chemical drugs.
SJ medical
